Symbol
| C1GALT1
| contributors: mct - updated : 14-11-2018
|
HGNC name
| core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1
|
HGNC id
| 24337
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
promotes breast cancer cell growth through MUC1-C signaling pathway  | |
Susceptibility
|
to IgA nephropathy (IGAN) |
Variant & Polymorphism
other
| variants of C1GALT1 associated with the genetic susceptibility to IgA nephropathy |
|
polymorphisms in the C1GALT1 gene were associated with genetic susceptibility to Uyghur IgAN  |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | endocrine | pancreas |  |
targeting C1GALT1 could be a promising approach for ovarian cancer therapy | cancer | reproductive | breast |  |
potential of C1GALT1 as a target of novel therapeutic agent development in breast cancer |
| | | |
| C1galt1-deficient mice exhibit thrombocytopenia due to abnormal terminal differentiation of megakaryocytes  |